American Capital Management Inc. Purchases 22,692 Shares of Merit Medical Systems, Inc. $MMSI

American Capital Management Inc. grew its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 24.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 115,775 shares of the medical instruments supplier’s stock after purchasing an additional 22,692 shares during the period. American Capital Management Inc.’s holdings in Merit Medical Systems were worth $7,980,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in MMSI. Wellington Management Group LLP grew its stake in Merit Medical Systems by 377.7% in the 3rd quarter. Wellington Management Group LLP now owns 1,240,509 shares of the medical instruments supplier’s stock worth $103,248,000 after buying an additional 980,823 shares in the last quarter. Norges Bank purchased a new stake in shares of Merit Medical Systems during the 4th quarter valued at $75,957,000. Iron Triangle Partners LP purchased a new stake in shares of Merit Medical Systems during the 4th quarter valued at $33,992,000. Champlain Investment Partners LLC bought a new stake in shares of Merit Medical Systems during the 4th quarter worth $32,359,000. Finally, Fifth Third Bancorp lifted its holdings in shares of Merit Medical Systems by 24,625.6% during the 1st quarter. Fifth Third Bancorp now owns 313,026 shares of the medical instruments supplier’s stock worth $21,577,000 after acquiring an additional 311,760 shares during the last quarter. Institutional investors own 99.66% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Piper Sandler reiterated an “overweight” rating on shares of Merit Medical Systems in a report on Friday, July 10th. Wells Fargo & Company decreased their price objective on Merit Medical Systems from $78.00 to $74.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. Wall Street Zen downgraded Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a research report on Sunday, April 5th. Barrington Research cut their target price on Merit Medical Systems from $109.00 to $107.00 and set an “outperform” rating for the company in a research note on Monday, April 20th. Finally, Needham & Company LLC reduced their price target on shares of Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Eight equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Merit Medical Systems currently has an average rating of “Moderate Buy” and a consensus price target of $92.80.

Insider Transactions at Merit Medical Systems

In related news, insider Brian G. Lloyd purchased 2,000 shares of the stock in a transaction dated Thursday, May 7th. The stock was purchased at an average price of $62.62 per share, with a total value of $125,240.00. Following the transaction, the insider directly owned 2,000 shares in the company, valued at $125,240. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Lynne N. Ward sold 5,000 shares of Merit Medical Systems stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $62.61, for a total transaction of $313,050.00. Following the completion of the transaction, the director directly owned 7,809 shares of the company’s stock, valued at $488,921.49. This trade represents a 39.04% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.70% of the company’s stock.

Merit Medical Systems Stock Up 2.4%

NASDAQ MMSI opened at $76.10 on Tuesday. The company has a debt-to-equity ratio of 0.45, a current ratio of 5.08 and a quick ratio of 3.46. The stock has a market capitalization of $4.54 billion, a PE ratio of 32.94, a PEG ratio of 2.31 and a beta of 0.52. Merit Medical Systems, Inc. has a 1 year low of $59.74 and a 1 year high of $94.75. The business’s 50-day moving average is $68.44 and its 200 day moving average is $71.89.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.84 by $0.10. Merit Medical Systems had a net margin of 9.03% and a return on equity of 13.54%. The business had revenue of $381.88 million for the quarter, compared to the consensus estimate of $377.59 million. During the same period in the previous year, the firm earned $0.86 EPS. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Sell-side analysts forecast that Merit Medical Systems, Inc. will post 3.62 earnings per share for the current year.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.